Matawan Pharmaceuticals (Retin-A Manufacturing Unit) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Matawan Pharmaceuticals (Retin-A Manufacturing Unit) General Information

Description

Manufacturer of a medicine for acne vulgaris. The business unit manufactures Retin-A medicinal drug used for the treatment of acne vulgaris.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Corporate Office
  • Cranford, NJ 07016
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Matawan Pharmaceuticals (Retin-A Manufacturing Unit) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Matawan Pharmaceuticals (Retin-A Manufacturing Unit)‘s full profile, request access.

Request a free trial

Matawan Pharmaceuticals (Retin-A Manufacturing Unit) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Matawan Pharmaceuticals (Retin-A Manufacturing Unit)‘s full profile, request access.

Request a free trial

Matawan Pharmaceuticals (Retin-A Manufacturing Unit) FAQs

  • Where is Matawan Pharmaceuticals (Retin-A Manufacturing Unit) headquartered?

    Matawan Pharmaceuticals (Retin-A Manufacturing Unit) is headquartered in Cranford, NJ.

  • What industry is Matawan Pharmaceuticals (Retin-A Manufacturing Unit) in?

    Matawan Pharmaceuticals (Retin-A Manufacturing Unit)’s primary industry is Pharmaceuticals.

  • Is Matawan Pharmaceuticals (Retin-A Manufacturing Unit) a private or public company?

    Matawan Pharmaceuticals (Retin-A Manufacturing Unit) is a Private company.

  • What is the current valuation of Matawan Pharmaceuticals (Retin-A Manufacturing Unit)?

    The current valuation of Matawan Pharmaceuticals (Retin-A Manufacturing Unit) is 00000.

  • What is Matawan Pharmaceuticals (Retin-A Manufacturing Unit)’s current revenue?

    The current revenue for Matawan Pharmaceuticals (Retin-A Manufacturing Unit) is 000000.

  • Who are Matawan Pharmaceuticals (Retin-A Manufacturing Unit)’s investors?

    Matawan Pharmaceuticals has invested in Matawan Pharmaceuticals (Retin-A Manufacturing Unit).

  • When was Matawan Pharmaceuticals (Retin-A Manufacturing Unit) acquired?

    Matawan Pharmaceuticals (Retin-A Manufacturing Unit) was acquired on 22-Jan-2016.

  • Who acquired Matawan Pharmaceuticals (Retin-A Manufacturing Unit)?

    Matawan Pharmaceuticals (Retin-A Manufacturing Unit) was acquired by Perrigo Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »